Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The '336 PATENT HAS BEEN APPROVED

But it appears that the '457 is is the only outstanding USPTO application based on the '336.*

*Assuming that the NIRC goes through the way we all hope..

Share
New Message
Please login to post a reply